Background Attention deficit hyperactivity disorder (ADHD) is one of the most commonly
diagnosed and treated psychiatric disorders in childhood. Typically, children and …

Background Attention deficit hyperactivity disorder (ADHD) is a common
neurodevelopmental disorder in childhood. The psychostimulant methylphenidate is the …

Pelham, Wheeler, and Chronis reviewed the treatment literature on attention-
deficit/hyperactivity disorder (ADHD) and concluded behavioral parent training (BPT) and …

Background: Medication is an important element of therapeutic strategies for ADHD. While
medications for ADHD are generally well‐tolerated, there are common, although less …

This article examines evidence-based assessment practices for attention deficit hyperactivity
disorder (ADHD). The nature, symptoms, associated features, and comorbidity of ADHD are …

Assessing impairment is an explicit component of current psychiatric diagnostic systems. A
brief parent and teacher rating scale for assessing impairment was developed and studied …

Traditionally, drug discovery utilises a de novo design approach, which requires high cost
and many years of drug development before it reaches the market. Novel drug development …

Using a cost of illness (COI) framework, this article examines the economic impact of
attention-deficit/hyperactivity disorder (ADHD) in childhood and adolescence. Our review of …

OBJECTIVE: This article summarizes information on scales assessing attention-
deficit/hyperactivity disorder (ADHD) in children and adolescents. METHOD: The authors …

Objective: To increase understanding of effect size calculations among clinicians who over-
rely on interpretations of P values in their assessment of the medical literature. Design: We …